Gitte Aabo

Sales & Marketing

Joining the pharmaphorum podcast for episode 24 is Gitte Aabo, who last year moved to hearing aid technology firm GN Hearing as CEO.

News

Belgian biotech UCB has made its second acquisition of the year, buying T-cell engager player Candid Therapeutics for up to $2.2 billion.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.